Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

SHE/002317 stock hub

SHE/002317 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

SHE/002317is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

19.2B

Shenzhen Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

SHE/002317

In the news

Latest news · SHE/002317

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 17.1P50 24.2P75 37.8

Trailing P/E68.3

P25 23.5P50 41.3P75 83.2

ROE6.9

P25 -0.9P50 4.1P75 8.8

ROIC23.6

P25 -0.5P50 5P75 11.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All SHE/002317 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

209

Groups with data

Currency

CNY

Showing 209 of 209 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	China
Country code	CN
Employees	1,775
Employees Change	43%
Employees Change Percent	2.48
Enterprise value	CNY 18.3B
Exchange	Shenzhen Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	CNE100000HW4
Last refreshed	2026-05-10
Market cap	CNY 19.2B
Price	CNY 22.54
Price currency	CNY
Rev Per Employee	1,430,116.96x
Sector	Healthcare
Sic	2834
Symbol	she/002317
Website	https://www.zspcl.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	1.53%
EV Earnings	62.34x
EV/EBIT	63.92x
EV/EBITDA	45.21x
EV/FCF	110.55x
EV/Sales	7.24x
FCF yield	0.86%
P/B ratio	4.62x
P/E ratio	68.3x
P/S ratio	7.62x
PE Ratio10 Y	39.19x
PE Ratio3 Y	60.32x
PE Ratio5 Y	55.91x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	12.19%
EBITDA Margin	16.73%
FCF margin	6.58%
Gross margin	56.1%
Gross Profit	CNY 1.4B
Gross Profit Growth	2.55%
Gross Profit Growth Q	-0.36%
Gross Profit Growth3 Y	-6.7%
Gross Profit Growth5 Y	0.05%
Net Income	CNY 293M
Net Income Growth Q	20.83%
Net Income Growth Quarters	5%
Net Income Growth Years	1%
Net Income Growth3 Y	-8.85%
Pretax Margin	12.54%
Profit Margin	11.66%
Profit Per Employee	CNY 166,742
Profitable Years	1
ROE	6.87
ROIC	23.57
Roic5y	12.75

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	8.87%
Cagr15y	10.37%
Cagr1y	98.92%
Cagr3y	6.1%
Cagr5y	23.66%
Div CAGR10	4.81%
Div CAGR3	0%
Div CAGR5	0%
EPS Growth Q	20
EPS Growth Quarters	2
EPS Growth Years	1
EPS Growth3 Y	-10.11
FCF Growth	8.86%
OCF Growth	22.3%
OCF Growth10 Y	3.59%
OCF Growth5 Y	30.41%
Revenue Growth	2.12x
Revenue Growth Q	-1.58x
Revenue Growth Years	1x
Revenue Growth3 Y	-2.93x
Revenue Growth5 Y	3.44x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Cash	CNY 1.3B
Debt	CNY 326.3M
Debt EBITDA	CNY 0.77
Debt Equity	CNY 0.08
Debt FCF	CNY 1.97
Equity	CNY 4.1B
Interest Coverage	61.27
Net Cash	CNY 984.1M
Net Cash By Market Cap	CNY 5.14
Net Debt EBITDA	CNY -2.34
Net Debt Equity	CNY -0.24
Net Debt FCF	CNY -5.96
Tangible Book Value	CNY 3.5B
WACC	6.89

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-1.61%
Dividend Growth	0%
Dividend Growth Years	0%
Dividend per share	CNY 0.2
Dividend Years	16
Dividend Yield	0.89%
Ex Div Date	2025-05-29
Last Dividend	CNY 0.2
Payout Frequency	Annual
Payout Ratio	58.15%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	133.86%
1Y total return	98.82%
200-day SMA	19.81
3Y total return	19.45%
50-day SMA	18.49
50-day SMA vs 200-day SMA	50under200
5Y total return	189.09%
All Time High	41.3
All Time High Change	-45.42%
All Time High Date	2022-11-22
All Time Low	4.73
All Time Low Change	377.04%
All Time Low Date	2012-01-16
ATR	0.94
Beta	0.5
Beta1y	0.45
Beta2y	0.6
Ch YTD	18.76
High	22.54
High52	27.97
High52 Date	2025-11-17
High52ch	-19.41%
Low	18.75
Low52	11.42
Low52 Date	2025-05-08
Low52ch	97.37%
Ma50ch	21.92%
Price vs 200-day SMA	13.8%
RSI	74.82
RSI Monthly	60.55
RSI Weekly	62.39
Sharpe ratio	1.53x
Sortino ratio	2.81
Total Return	-0.72%
Tr YTD	18.76
Tr15y	339.27%
Tr1m	20.54%
Tr1w	20.99%
Tr3m	14.88%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CNY 306.2M
Operating Income Growth	17.7
Operating Income Growth Q	28.95
Operating Income Growth3 Y	-2.57
Operating Income Growth5 Y	2.21
Operating margin	12.19

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	615,422,731%
Net Borrowing	-56,202,985
Shares Insiders	27.59%
Shares Institutions	9.89%
Shares Out	849,930,477
Shares Qo Q	-0.58%
Shares Yo Y	1.61%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CNY 165.2M
Average Volume	31,161,685.05x
CAPEX	CNY -310.1M
Ch10y	99.29
Ch15y	248.4
Ch1m	20.54
Ch1w	20.99
Ch1y	95.66
Ch3m	14.88
Ch3y	14.53
Ch5y	167.7
Ch6m	7.9
Change	10%
Change From Open	0
Close	20.49
Days Gap	10
Depreciation Amortization	124,106,850
Dollar Volume	920,669,313.3
Earnings Date	2026-04-29
EBIT	CNY 306.2M
EBITDA	CNY 420.3M
EPS	CNY 0.35
F Score	4
FCF	CNY 165.2M
FCF EV Yield	0.9x
FCF Per Share	CNY 0.19
Financing CF	-369,799,711
Fiscal Year End	December
Founded	1,979
Income Tax	CNY 31.7M
Investing CF	-327,245,221
Is Primary Listing	1
Last Earnings Date	2026-04-29
Last Report Date	2026-03-31
Last Split Date	2015-09-01
Last Split Type	Forward
Lynch Fair Value	CNY 1.76
Lynch Upside	-92.19
Ma150	19.77
Ma150ch	14.02%
Ma20	18.86
Ma20ch	19.53%
Net CF	-221,740,127
Next Earnings Date	2026-08-28
Open	22.54
P FCF Ratio	115.9
P OCF Ratio	40.3
Payment Date	2025-05-29
Position In Range	100
Price Date	2026-05-08
Price EBITDA	CNY 45.58
Ptbv Ratio	5.4
Relative Volume	1.31x
Revenue	2,512,715,499x
Tax By Revenue	1.26x
Tax Rate	10.07%
Tr6m	7.9%
Volume	40,846,021

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

SHE/002317 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+0.9%

$0.20 annual per share

Payout ratio

+58.2%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

0.0%

0 consecutive years of growth

Total shareholder yield

-0.7%

Next ex-dividend date: 2025-05-29

Performance

SHE/002317 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns SHE/002317?

Insider, institutional, and short-interest positioning.

Institutional ownership

+9.9%

Share of float held by funds and institutions

Insider ownership

+27.6%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+1.6%

Negative means the company is buying back shares.

Technical

SHE/002317 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

74.8

Above 70: short-term overbought

Price vs 200-day MA

+13.8%

50/200-day relationship not available

Beta (5Y)

0.50

Less volatile than the market

Sharpe ratio

1.53

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About SHE/002317

Hub-level FAQ points readers to the deeper analysis pages.

What is the current she/002317 stock rating?

she/002317 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full she/002317 analysis?

The full report lives at /stocks/she/002317/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for she/002317?

The latest report frames she/002317 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the she/002317 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.